GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $53,000 | -99.4% | 1,250 | -99.3% | 0.02% | -99.4% |
| Q3 2014 | $8,205,000 | -7.2% | 178,496 | +7.9% | 3.41% | -12.3% |
| Q2 2014 | $8,845,000 | +9.7% | 165,387 | +9.6% | 3.89% | -1.2% |
| Q1 2014 | $8,065,000 | +20.1% | 150,941 | +20.0% | 3.94% | +0.8% |
| Q4 2013 | $6,715,000 | +7.0% | 125,781 | +0.6% | 3.91% | +2.6% |
| Q3 2013 | $6,276,000 | +8.3% | 125,086 | +7.8% | 3.81% | +2.9% |
| Q2 2013 | $5,797,000 | +21.1% | 116,000 | +13.7% | 3.70% | +1.8% |
| Q1 2013 | $4,787,000 | – | 102,057 | – | 3.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |